Resmed CDI (ASX:RMD)
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) share price news
OncoSil Medical Ltd (ASX:OSL) Smashed – Down 68%
With the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO) down 1% some investors might be asking ‘what on earth has happened to OncoSil Medical Ltd (ASX: OSL)’?
January Recap: What Happened To The ASX 200?
After 2018 saw the S&P/ASX 200 (INDEXASX:XJO) drop by 6.9%, investors were offered some relief in January with the market rebounding to finish the month 4.25% higher.
4 Reasons To Be Bullish About ResMed (ASX:RMD) Shares Despite The Selloff
The ResMed Inc (ASX:RMD) share price is down another 9.2% so far today, but there are reasons to remain positive about the healthcare business.
Here’s Why ResMed (ASX:RMD) Shares Are Down 12% On Q2 Results
The ResMed Inc (ASX:RMD) share price is down nearly 11% after announcing its result for the second quarter of FY19.
ALL ORDINARIES Index Higher, AMP (ASX:AMP) Shares Drop
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX: XAO), is currently up 0.40% at lunch.
Did You See ResMed’s (ASX:RMD) Latest Takeover?
This week, ResMed Inc. (ASX:RMD) announced it will be acquiring MatrixCare for US$750 million.
ALL ORDINARIES Index Up, Amcor (ASX:AMC) Shares Rise
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.24% at lunch.
Investors Breathe Easy On ResMed Inc (ASX:RMD) First Quarter Result
ResMed Inc (ASX:RMD) has reported its result for the first quarter of the 2019 financial year.
S&P/ASX 200 News Friday
Here are the stories from the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and Australian finance circles on Friday.